Literature DB >> 10718400

Association of aberrant p53 and p21(WAF1) immunoreactivity with the outcome of oral verrucous leukoplakia in Taiwan.

K W Chang1, S C Lin, P C Kwan, Y K Wong.   

Abstract

The expression of p53 and p21WAF1 in 53 oral verrucous leukoplakias (OVLs), mostly non-dysplastic lesions, was investigated to ascertain the role of such events in malignant conversion. Immunohistochemical analysis revealed aberrant p53 and p21WAF1 immunoreactivity in 51% (27 cases) and 75% (40 cases), respectively. After an average follow-up period of three and a half years, histopathological examination revealed that 22 (42%) cases had developed oral squamous cell carcinoma (OSCC), 14 (26%) cases had undergone recurrence, and 17 (32%) cases were free of disease. The oncogenic potential of this subset of premalignant lesions warrants attention. A significant difference in the frequency of OSCC progression/recurrence was noted in lesions bearing aberrant immunoreactivity of either p53 (93% vs 42%; P=0.00008) or p21WAF1 (80% vs 32%; P=0.002) in comparison with lesions without immunoreactivity. This study suggested that the aberrant immunoreactivity of p53 and p21WAF1 may represent important alterations of OVL and could affect the outcome of this lesion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718400     DOI: 10.1034/j.1600-0714.2000.290202.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

1.  Stress activated p38 MAPK regulates cell cycle via AP-1 factors in areca extract exposed human lung epithelial cells.

Authors:  Rashmi Nagesh; K M Kiran Kumar; M Naveen Kumar; Rajeshwari H Patil; S Chidananda Sharma
Journal:  Cytotechnology       Date:  2019-02-02       Impact factor: 2.058

Review 2.  Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Biomark Cancer       Date:  2013-10-10

Review 3.  Hospital-based epidemiological and clinical characterisation of the malignant transformation of oral leukoplakia in a Chinese population.

Authors:  Ming-Yue Lyu; Yu-Si Guo; Shuo Li; Di Yang; Hong Hua
Journal:  Int Dent J       Date:  2017-03-09       Impact factor: 2.607

4.  Oral verrucous hyperplasia versus oral verrucous carcinoma: A clinicopathologic dilemma revisited using p53 as immunohistochemical marker.

Authors:  Preeti Sharma; Vijay Wadhwan; Pooja Aggarwal; Anamika Sharma
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec

Review 5.  Molecular markers associated with potentially malignant oral lesions (Review).

Authors:  Oana Mihaela Condurache Hritcu; Ana Emanuela Botez; Doinita Temelie Olinici; P Onofrei; Laura Stoica; V B Grecu; Paula Mihaela Toader; Laura Gheucă-Solovăstru; Elena Carmen Cotrutz
Journal:  Exp Ther Med       Date:  2021-06-04       Impact factor: 2.447

Review 6.  The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review).

Authors:  Mario Pérez-Sayáns; José-Manuel Suárez-Peñaranda; Pilar Gayoso-Diz; Francisco Barros-Angueira; José-Manuel Gándara-Rey; Abel García-García
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-03-01

7.  The upregulation of oncogenic miRNAs in swabbed samples obtained from oral premalignant and malignant lesions.

Authors:  Shu-Chun Lin; Chung-Ji Liu; Si-Hua Ji; Wan-Wen Hung; Ying-Chieh Liu; Sih-Rou Chang; Hsi-Feng Tu; Kuo-Wei Chang
Journal:  Clin Oral Investig       Date:  2021-08-03       Impact factor: 3.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.